{"entity":{"type":"insider","cik":"0001846487","url":"/insider/0001846487","json_url":"/insider/0001846487.json","name":"Mutz Christopher","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":11,"n_filings":10,"first":"2023-11-13","last":"2026-03-13","span_basis":"filed_date"},"name_variants":[{"name":"Mutz Christopher","source":"filing","n_filings":10,"first_seen":"2023-11-13","last_seen":"2026-03-13"}],"transactions":[{"id":6032044,"accession":"0001846487-26-000014","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001846487-26-000014","line_url":"/filing/0001846487-26-000014#line-1","is_derivative":false,"issuer_cik":"0001023024","issuer_name":"ANI PHARMACEUTICALS INC","issuer_ticker":"ANIP","issuer_name_source":null,"issuer_url":"/issuer/0001023024","owner_cik":"0001846487","owner_name":"Mutz Christopher","owner_display_name":"Mutz Christopher","owner_url":"/insider/0001846487","role":"Officer (HEAD OF RARE DISEASE)","role_mark":"O","role_mark_label":"Officer (HEAD OF RARE DISEASE)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"HEAD OF RARE DISEASE","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3162.0,"shares_display":"3,162","price_per_share":71.64,"price_display":"71.64","price_state":"stated","total_value":226525.68,"total_display":"226,525.68","total_whole":"226,526","shares_owned_after":91309.0,"shares_owned_after_display":"91,309","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-13","filed_date":"2026-03-13","scope":"insider"},{"id":5970796,"accession":"0001846487-26-000012","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001846487-26-000012","line_url":"/filing/0001846487-26-000012#line-3","is_derivative":false,"issuer_cik":"0001023024","issuer_name":"ANI PHARMACEUTICALS INC","issuer_ticker":"ANIP","issuer_name_source":null,"issuer_url":"/issuer/0001023024","owner_cik":"0001846487","owner_name":"Mutz Christopher","owner_display_name":"Mutz Christopher","owner_url":"/insider/0001846487","role":"Officer (HEAD OF RARE DISEASE)","role_mark":"O","role_mark_label":"Officer (HEAD OF RARE DISEASE)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"HEAD OF RARE DISEASE","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3602.0,"shares_display":"3,602","price_per_share":74.18,"price_display":"74.18","price_state":"stated","total_value":267196.36,"total_display":"267,196.36","total_whole":"267,196","shares_owned_after":94471.0,"shares_owned_after_display":"94,471","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-09","filed_date":"2026-03-10","scope":"insider"},{"id":5970789,"accession":"0001846487-26-000012","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001846487-26-000012","line_url":"/filing/0001846487-26-000012#line-1","is_derivative":false,"issuer_cik":"0001023024","issuer_name":"ANI PHARMACEUTICALS INC","issuer_ticker":"ANIP","issuer_name_source":null,"issuer_url":"/issuer/0001023024","owner_cik":"0001846487","owner_name":"Mutz Christopher","owner_display_name":"Mutz Christopher","owner_url":"/insider/0001846487","role":"Officer (HEAD OF RARE DISEASE)","role_mark":"O","role_mark_label":"Officer (HEAD OF RARE DISEASE)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"HEAD OF RARE DISEASE","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2121.0,"shares_display":"2,121","price_per_share":74.22,"price_display":"74.22","price_state":"stated","total_value":157420.62,"total_display":"157,420.62","total_whole":"157,421","shares_owned_after":101387.0,"shares_owned_after_display":"101,387","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-06","filed_date":"2026-03-10","scope":"insider"},{"id":6160122,"accession":"0001846487-26-000010","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001846487-26-000010","line_url":"/filing/0001846487-26-000010#line-1","is_derivative":false,"issuer_cik":"0001023024","issuer_name":"ANI PHARMACEUTICALS INC","issuer_ticker":"ANIP","issuer_name_source":null,"issuer_url":"/issuer/0001023024","owner_cik":"0001846487","owner_name":"Mutz Christopher","owner_display_name":"Mutz Christopher","owner_url":"/insider/0001846487","role":"Officer (HEAD OF RARE DISEASE)","role_mark":"O","role_mark_label":"Officer (HEAD OF RARE DISEASE)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"HEAD OF RARE DISEASE","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":417.0,"shares_display":"417","price_per_share":74.0,"price_display":"74.00","price_state":"stated","total_value":30858.0,"total_display":"30,858.00","total_whole":"30,858","shares_owned_after":103508.0,"shares_owned_after_display":"103,508","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-02","filed_date":"2026-03-04","scope":"insider"},{"id":6205822,"accession":"0001846487-26-000006","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001846487-26-000006","line_url":"/filing/0001846487-26-000006#line-1","is_derivative":false,"issuer_cik":"0001023024","issuer_name":"ANI PHARMACEUTICALS INC","issuer_ticker":"ANIP","issuer_name_source":null,"issuer_url":"/issuer/0001023024","owner_cik":"0001846487","owner_name":"Mutz Christopher","owner_display_name":"Mutz Christopher","owner_url":"/insider/0001846487","role":"Officer (HEAD OF RARE DISEASE)","role_mark":"O","role_mark_label":"Officer (HEAD OF RARE DISEASE)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"HEAD OF RARE DISEASE","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5323.0,"shares_display":"5,323","price_per_share":78.02,"price_display":"78.02","price_state":"stated","total_value":415300.46,"total_display":"415,300.46","total_whole":"415,300","shares_owned_after":84840.0,"shares_owned_after_display":"84,840","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-20","filed_date":"2026-02-23","scope":"insider"},{"id":5950653,"accession":"0001846487-26-000004","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001846487-26-000004","line_url":"/filing/0001846487-26-000004#line-2","is_derivative":false,"issuer_cik":"0001023024","issuer_name":"ANI PHARMACEUTICALS INC","issuer_ticker":"ANIP","issuer_name_source":null,"issuer_url":"/issuer/0001023024","owner_cik":"0001846487","owner_name":"Mutz Christopher","owner_display_name":"Mutz Christopher","owner_url":"/insider/0001846487","role":"Officer (HEAD OF RARE DISEASE)","role_mark":"O","role_mark_label":"Officer (HEAD OF RARE DISEASE)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"HEAD OF RARE DISEASE","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7032.0,"shares_display":"7,032","price_per_share":76.55,"price_display":"76.55","price_state":"stated","total_value":538299.6,"total_display":"538,299.60","total_whole":"538,300","shares_owned_after":92566.0,"shares_owned_after_display":"92,566","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-12","filed_date":"2026-02-17","scope":"insider"},{"id":4187235,"accession":"0001846487-25-000008","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001846487-25-000008","line_url":"/filing/0001846487-25-000008#line-1","is_derivative":false,"issuer_cik":"0001023024","issuer_name":"ANI PHARMACEUTICALS INC","issuer_ticker":"ANIP","issuer_name_source":null,"issuer_url":"/issuer/0001023024","owner_cik":"0001846487","owner_name":"Mutz Christopher","owner_display_name":"Mutz Christopher","owner_url":"/insider/0001846487","role":"Officer (HEAD OF RARE DISEASE)","role_mark":"O","role_mark_label":"Officer (HEAD OF RARE DISEASE)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"HEAD OF RARE DISEASE","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":60.45,"price_display":"60.45","price_state":"stated","total_value":241800.0,"total_display":"241,800.00","total_whole":"241,800","shares_owned_after":107317.0,"shares_owned_after_display":"107,317","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-14","filed_date":"2025-05-15","scope":"insider"},{"id":2261321,"accession":"0001846487-24-000014","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001846487-24-000014","line_url":"/filing/0001846487-24-000014#line-1","is_derivative":false,"issuer_cik":"0001023024","issuer_name":"ANI PHARMACEUTICALS INC","issuer_ticker":"ANIP","issuer_name_source":null,"issuer_url":"/issuer/0001023024","owner_cik":"0001846487","owner_name":"Mutz Christopher","owner_display_name":"Mutz Christopher","owner_url":"/insider/0001846487","role":"Officer (HEAD OF RARE DISEASE)","role_mark":"O","role_mark_label":"Officer (HEAD OF RARE DISEASE)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"HEAD OF RARE DISEASE","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6500.0,"shares_display":"6,500","price_per_share":57.7,"price_display":"57.70","price_state":"stated","total_value":375050.0,"total_display":"375,050.00","total_whole":"375,050","shares_owned_after":76777.0,"shares_owned_after_display":"76,777","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-15","filed_date":"2024-11-18","scope":"insider"},{"id":2809728,"accession":"0001846487-24-000012","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001846487-24-000012","line_url":"/filing/0001846487-24-000012#line-1","is_derivative":false,"issuer_cik":"0001023024","issuer_name":"ANI PHARMACEUTICALS INC","issuer_ticker":"ANIP","issuer_name_source":null,"issuer_url":"/issuer/0001023024","owner_cik":"0001846487","owner_name":"Mutz Christopher","owner_display_name":"Mutz Christopher","owner_url":"/insider/0001846487","role":"Officer (HEAD OF RARE DISEASE)","role_mark":"O","role_mark_label":"Officer (HEAD OF RARE DISEASE)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"HEAD OF RARE DISEASE","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":61.61,"price_display":"61.61","price_state":"stated","total_value":123220.0,"total_display":"123,220.00","total_whole":"123,220","shares_owned_after":83277.0,"shares_owned_after_display":"83,277","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-21","filed_date":"2024-05-22","scope":"insider"},{"id":2295952,"accession":"0001846487-24-000008","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001846487-24-000008","line_url":"/filing/0001846487-24-000008#line-1","is_derivative":false,"issuer_cik":"0001023024","issuer_name":"ANI PHARMACEUTICALS INC","issuer_ticker":"ANIP","issuer_name_source":null,"issuer_url":"/issuer/0001023024","owner_cik":"0001846487","owner_name":"Mutz Christopher","owner_display_name":"Mutz Christopher","owner_url":"/insider/0001846487","role":"Officer (HEAD OF RARE DISEASE)","role_mark":"O","role_mark_label":"Officer (HEAD OF RARE DISEASE)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"HEAD OF RARE DISEASE","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":66.0,"price_display":"66.00","price_state":"stated","total_value":330000.0,"total_display":"330,000.00","total_whole":"330,000","shares_owned_after":87387.0,"shares_owned_after_display":"87,387","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-05","filed_date":"2024-03-06","scope":"insider"},{"id":8692197,"accession":"0001846487-23-000003","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001846487-23-000003","line_url":"/filing/0001846487-23-000003#line-1","is_derivative":false,"issuer_cik":"0001023024","issuer_name":"ANI PHARMACEUTICALS INC","issuer_ticker":"ANIP","issuer_name_source":null,"issuer_url":"/issuer/0001023024","owner_cik":"0001846487","owner_name":"Mutz Christopher","owner_display_name":"Mutz Christopher","owner_url":"/insider/0001846487","role":"Officer (HEAD OF RARE DISEASE)","role_mark":"O","role_mark_label":"Officer (HEAD OF RARE DISEASE)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"HEAD OF RARE DISEASE","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":52.47,"price_display":"52.47","price_state":"stated","total_value":157410.0,"total_display":"157,410.00","total_whole":"157,410","shares_owned_after":63607.0,"shares_owned_after_display":"63,607","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-10","filed_date":"2023-11-13","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":11,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":11,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":11},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001023024","name":"ANI PHARMACEUTICALS INC","url":"/issuer/0001023024","role":"Officer (HEAD OF RARE DISEASE)","n_filings":10,"first_seen":"2023-11-13","last_seen":"2026-03-13"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001846487","retrieved_at":"2026-08-22T11:35:24+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}